Correlation Between X4 Pharmaceuticals and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Immix Biopharma, you can compare the effects of market volatilities on X4 Pharmaceuticals and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Immix Biopharma.
Diversification Opportunities for X4 Pharmaceuticals and Immix Biopharma
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between XFOR and Immix is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Immix Biopharma go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Immix Biopharma
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 4.33 times more return on investment than Immix Biopharma. However, X4 Pharmaceuticals is 4.33 times more volatile than Immix Biopharma. It trades about 0.04 of its potential returns per unit of risk. Immix Biopharma is currently generating about -0.27 per unit of risk. If you would invest 74.00 in X4 Pharmaceuticals on November 4, 2024 and sell it today you would lose (4.00) from holding X4 Pharmaceuticals or give up 5.41% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
X4 Pharmaceuticals vs. Immix Biopharma
Performance |
Timeline |
X4 Pharmaceuticals |
Immix Biopharma |
X4 Pharmaceuticals and Immix Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with X4 Pharmaceuticals and Immix Biopharma
The main advantage of trading using opposite X4 Pharmaceuticals and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |